Enabling global access to high-quality biopharmaceuticals
暂无分享,去创建一个
Kerry Routenberg Love | Paul W. Barone | J. Christopher Love | J. C. Love | P. Barone | K. Love | J. C. Love | Paul W Barone
[1] Alisa Opar,et al. 'Pharmers' hope for first plant drug harvest , 2011, Nature Reviews Drug Discovery.
[2] Ron Diskin,et al. HIV therapy by a combination of broadly neutralizing antibodies in humanized mice , 2012, Nature.
[3] E. Galun,et al. A Plant-Derived Recombinant Human Glucocerebrosidase Enzyme—A Preclinical and Phase I Investigation , 2009, PloS one.
[4] T. Przybycien,et al. Alternative bioseparation operations: life beyond packed-bed chromatography. , 2004, Current opinion in biotechnology.
[5] Peter Wiktor,et al. NanoMonitor: a miniature electronic biosensor for glycan biomarker detection. , 2010, Nanomedicine.
[6] Youwei Jiang,et al. Optimization of humanized IgGs in glycoengineered Pichia pastoris , 2006, Nature Biotechnology.
[7] Duncan Low,et al. Future of antibody purification. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[8] Saurabh Aggarwal,et al. What's fueling the biotech engine—2011 to 2012 , 2012, Nature Biotechnology.
[9] Rajeev J Ram,et al. In situ bioprocess monitoring of Escherichia coli bioreactions using Raman spectroscopy , 2004 .
[10] Gary Walsh,et al. Biopharmaceutical benchmarks 2010 , 2010, Nature Biotechnology.
[11] Randy Osborne. Fresh from the biotech pipeline—2012 , 2013, Nature Biotechnology.
[12] Suzanne S Farid,et al. Process economics of industrial monoclonal antibody manufacture. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] Lora Hamuro,et al. The Impact of Glycosylation on the Pharmacokinetics of a TNFR2:Fc Fusion Protein Expressed in Glycoengineered Pichia Pastoris , 2012, Pharmaceutical Research.
[14] Yves-Jacques Schneider,et al. Insect cells as factories for biomanufacturing. , 2012, Biotechnology advances.
[15] Pingzuo Li,et al. Expression of Recombinant Proteins in Pichia Pastoris , 2007, Applied biochemistry and biotechnology.
[16] Manon M J Cox,et al. Recombinant protein vaccines produced in insect cells , 2012, Vaccine.
[17] Jörg Thömmes,et al. Alternatives to Chromatographic Separations , 2007, Biotechnology progress.
[18] Jongyoon Han,et al. Artificial molecular sieves and filters: a new paradigm for biomolecule separation. , 2008, Trends in biotechnology.
[19] T. Gerngross,et al. Glycosylation engineering in yeast: the advent of fully humanized yeast. , 2007, Current opinion in biotechnology.
[20] Laura Neumann,et al. Engineering of Sialylated Mucin-type O-Glycosylation in Plants , 2012, The Journal of Biological Chemistry.
[21] A Batson. The costs and economics of modern vaccine development. , 2002, Developments in biologicals.
[22] Pascal Poignard,et al. Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques , 2009, Nature Medicine.
[23] Nuala Moran,et al. Biotech innovators jump on biosimilars bandwagon , 2012, Nature Biotechnology.
[24] M. Mccamish,et al. Worldwide experience with biosimilar development , 2011, mAbs.
[25] Gary Walsh,et al. Biopharmaceuticals: Biochemistry and Biotechnology , 1998 .
[26] T. Osslund,et al. Crystallization and liquid‐liquid phase separation of monoclonal antibodies and fc‐fusion proteins: Screening results , 2011, Biotechnology progress.
[27] Renate Kunert,et al. In Planta Protein Sialylation through Overexpression of the Respective Mammalian Pathway* , 2010, The Journal of Biological Chemistry.
[28] J W Larrick,et al. Producing proteins in transgenic plants and animals. , 2001, Current opinion in biotechnology.
[29] Pete Gagnon. Steric Exclusion Chromatography , 2013 .
[30] Daniel Cummings,et al. Integrated continuous production of recombinant therapeutic proteins , 2012, Biotechnology and bioengineering.
[31] Sascha Beutel,et al. In situ sensor techniques in modern bioprocess monitoring , 2011, Applied Microbiology and Biotechnology.
[32] J. F. Stefanick,et al. Nonchromatographic affinity precipitation method for the purification of bivalently active pharmaceutical antibodies from biological fluids. , 2013, Analytical chemistry.
[33] Bernd Kammerer,et al. Towards Protein Crystallization as a Process Step in Downstream Processing of Therapeutic Antibodies: Screening and Optimization at Microbatch Scale , 2011, PloS one.
[34] Nicholas R. Abu-Absi,et al. Real time monitoring of multiple parameters in mammalian cell culture bioreactors using an in-line Raman spectroscopy probe. , 2011, Biotechnology and bioengineering.
[35] Thomayant Prueksaritanont,et al. The impact of sialic acids on the pharmacokinetics of a PEGylated erythropoietin. , 2012, Journal of pharmaceutical sciences.
[36] D. Dimitrov,et al. Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design , 2013, Expert opinion on biological therapy.
[37] Jongyoon Han,et al. Continuous-flow bioseparation using microfabricated anisotropic nanofluidic sieving structures , 2009, Nature Protocols.
[38] Frank Riske,et al. Periodic counter-current chromatography -- design and operational considerations for integrated and continuous purification of proteins. , 2012, Biotechnology journal.
[39] Ardemis A. Boghossian,et al. Transduction of glycan-lectin binding using near-infrared fluorescent single-walled carbon nanotubes for glycan profiling. , 2011, Journal of the American Chemical Society.
[40] Alan D. Lopez,et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis , 2011, The Lancet.
[41] Manon M J Cox,et al. FluBlok, a next generation influenza vaccine manufactured in insect cells. , 2009, Biologicals : journal of the International Association of Biological Standardization.
[42] Pete Gagnon,et al. Principles and applications of steric exclusion chromatography. , 2012, Journal of chromatography. A.
[43] Martin H. Koldijk,et al. The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. , 2001, Vaccine.
[44] Peter P. Gray,et al. New frontiers in cell line development: challenges for biosimilars , 2011 .
[45] Jon Cohen. AIDS research. More woes for struggling HIV vaccine field. , 2013, Science.
[46] Gheona Altarescu,et al. disease taliglucerase alfa , a novel enzyme replacement therapy for Gaucher expressed recombinant glucocerebrosidase , − Pivotal trial with plant cell , 2012 .
[47] Roland Contreras,et al. Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology , 2008, Nature Protocols.
[48] Brian Kelley,et al. Industrialization of mAb production technology: The bioprocessing industry at a crossroads , 2009, mAbs.